NTRA Natera's Signatera MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.